Rui Zhou

3.9k total citations · 2 hit papers
86 papers, 2.8k citations indexed

About

Rui Zhou is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Rui Zhou has authored 86 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 34 papers in Cancer Research and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Rui Zhou's work include MicroRNA in disease regulation (19 papers), RNA modifications and cancer (11 papers) and Cancer-related molecular mechanisms research (9 papers). Rui Zhou is often cited by papers focused on MicroRNA in disease regulation (19 papers), RNA modifications and cancer (11 papers) and Cancer-related molecular mechanisms research (9 papers). Rui Zhou collaborates with scholars based in China, United States and South Korea. Rui Zhou's co-authors include Xian‐Ming Chen, Guoku Hu, Qiang Lü, Haiwei Yang, Jie Han, Hongcheng Lu, Xiao Yang, Ji‐Fu Wei, Hao Yu and Wenbo Yuan and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Rui Zhou

85 papers receiving 2.8k citations

Hit Papers

METTL3 promote tumor proliferation of bladder cancer by a... 2019 2026 2021 2023 2019 2021 100 200 300 400 500

Peers

Rui Zhou
Jian Xu China
Bo Tang China
Peng Qi China
Kai Li China
Jian Xu China
Rui Zhou
Citations per year, relative to Rui Zhou Rui Zhou (= 1×) peers Jian Xu

Countries citing papers authored by Rui Zhou

Since Specialization
Citations

This map shows the geographic impact of Rui Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Zhou more than expected).

Fields of papers citing papers by Rui Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Zhou. The network helps show where Rui Zhou may publish in the future.

Co-authorship network of co-authors of Rui Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Rui Zhou. A scholar is included among the top collaborators of Rui Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Zhou. Rui Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yujie, Ling Wu, Jie He, et al.. (2025). Inhibition of CCT5-mediated asparagine biosynthesis and anti-PD-L1 produce synergistic antitumor effects in colorectal cancer. Acta Pharmaceutica Sinica B. 15(5). 2480–2497. 1 indexed citations
2.
Liu, Chang, Rui Zhou, Hai-Ying Chen, et al.. (2025). Inflammatory microenvironment-responsive nanomicelles for acute lung injury therapy: ROS-scavenging and macrophage repolarization. Materials Today Bio. 31. 101622–101622. 7 indexed citations
3.
Zhou, Rui, et al.. (2025). Grain Yield Prediction Based on the Improved Unbiased Grey Markov Model. Discrete Dynamics in Nature and Society. 2025(1). 1 indexed citations
4.
Wang, Beini, Rui Zhou, Jin Wu, Hangun Kim, & Kwonseop Kim. (2024). Inhibition of δ-catenin palmitoylation slows the progression of prostate cancer. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1871(5). 119741–119741. 2 indexed citations
7.
Yang, Inho, Jihye Lee, Sunghoon Hwang, et al.. (2024). Anithiactin D, a Phenylthiazole Natural Product from Mudflat-Derived Streptomyces sp., Suppresses Motility of Cancer Cells. Marine Drugs. 22(2). 88–88. 4 indexed citations
8.
Zhou, Rui, Jie Chen, Yunxiuxiu Xu, et al.. (2023). PRPF19 facilitates colorectal cancer liver metastasis through activation of the Src-YAP1 pathway via K63-linked ubiquitination of MYL9. Cell Death and Disease. 14(4). 258–258. 11 indexed citations
9.
Zhou, Rui, et al.. (2023). Comprehensive exploration of the involvement of cuproptosis in tumorigenesis and progression of neuroblastoma. BMC Genomics. 24(1). 715–715. 5 indexed citations
10.
Zou, Zhaowei, et al.. (2022). PRRX1 promotes colorectal cancer stemness and chemoresistance via the JAK2/STAT3 axis by targeting IL-6. Journal of Gastrointestinal Oncology. 13(6). 2989–3008. 8 indexed citations
11.
Li, Ruidong, Han Qu, Shibo Wang, et al.. (2021). CancerMIRNome: an interactive analysis and visualization database for miRNome profiles of human cancer. Nucleic Acids Research. 50(D1). D1139–D1146. 83 indexed citations
12.
Li, Ruidong, Shibo Wang, Yanru Cui, et al.. (2020). Extended application of genomic selection to screen multiomics data for prognostic signatures of prostate cancer. Briefings in Bioinformatics. 22(3). 13 indexed citations
13.
Zhu, Jing, Rui Zhou, & Binglan Zhang. (2019). A comparison of regorafenib and fruquintinib for metastatic colorectal cancer: a systematic review and network meta-analysis. Journal of Cancer Research and Clinical Oncology. 145(9). 2313–2323. 17 indexed citations
14.
Han, Jie, Xiao Yang, Hao Yu, et al.. (2019). METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner. Molecular Cancer. 18(1). 110–110. 546 indexed citations breakdown →
15.
Yang, Yi, Woo Kyun Bae, Ji-Yoon Lee, et al.. (2018). Potassium usnate, a water-soluble usnic acid salt, shows enhanced bioavailability and inhibits invasion and metastasis in colorectal cancer. Scientific Reports. 8(1). 16234–16234. 34 indexed citations
16.
Zhou, Rui, Yi Yang, So‐Yeon Park, et al.. (2017). The lichen secondary metabolite atranorin suppresses lung cancer cell motility and tumorigenesis. Scientific Reports. 7(1). 8136–8136. 67 indexed citations
17.
Zhou, Rui, Chen Liu, Yaofeng Wang, et al.. (2017). MicroRNA-105 is involved in TNF-α-related tumor microenvironment enhanced colorectal cancer progression. Cell Death and Disease. 8(12). 3213–3213. 74 indexed citations
18.
Xia, Zijie, et al.. (2015). Upregulation of KSRP by miR-27b provides IFN-γ-induced post-transcriptional regulation of CX3CL1 in liver epithelial cells. Scientific Reports. 5(1). 17590–17590. 12 indexed citations
19.
Liu, Jun, et al.. (2010). ヒト胆管細胞においてICAM-1翻訳を抑制してインターフェロン-γ誘発性ICAM-1発現を調整するmiR-221. American Journal of Physiology-Legacy Content. 298. 542–550. 1 indexed citations
20.
Gong, Ai‐Yu, Rui Zhou, Guoku Hu, et al.. (2009). MicroRNA-513 Regulates B7-H1 Translation and Is Involved in IFN-γ-Induced B7-H1 Expression in Cholangiocytes. The Journal of Immunology. 182(3). 1325–1333. 175 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026